The market is in risk-off mode and likely to finish September with a loss. Blame seasonality, as well as a slew of singular threats. Read More

Analyst Articles
Here is one way to book a huge profit if this deal falls apart before it is consummated. Read More
Our editorial director spoke with investment expert Dr. Joe Duarte about several timely topics that are relevant to your financial health. Read More
Legislation to provide marijuana companies freer access to financial services is seeing renewed life in Congress. Read More
Expect markets to move after the Fed's decision this week. Especially important will be action in artificial intelligence and commodities. Read More
The Fed paused its rate hikes Wednesday, a widely expected move. But that’s already old news. What matters more is what comes next. Read More
Compounding earns you a larger return the more frequently it occurs. This dynamic can make you additional money when it comes to stocks too. Read More
We face a trilogy of risks in coming days: Fed policy, the UAW strike, and wrangling in Congress over the federal budget. Read More
Pot stocks have endured a bumpy ride this year, but cannabis investments are laying the groundwork for upward trajectory next year. Read More
This week, I analyze the most undervalued and overvalued stocks in the S&P 500 according to one popular metric. Read More